Souhaitez-vous accéder aux communiqués récents ?

Kraig Labs (OTCQB: KBLB) is a biotech company positioned at the intersection of genetic engineering, materials science, and textile manufacturing.

Cathie Wood and ARK Invest are making a decisive pivot that signals where the next phase of AI value creation may emerge: healthcare

Kraig Labs (OTCQB: KBLB) successfully deployed more than 700,000 BAM-1 Alpha production hybrids.

Kraig Labs (OTCQB: KBLB) significantly expanded its R&D capacity to keep pace with rapid progress of its Project Atlas advanced materials initiative

Kraig Labs (OTCQB: KBLB) plans to use multiple production facilities in Vietnam to produce around 10 metric tons of recombinant spider-silk cocoons per mon

Unicorns are usually $1 billion private companies, backed by institutional players and Kraig Labs (OTCQB: KBLB) is advancing a $billion platform

BERKELEY, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial...

The White House and President Trump expanding funding under DPA Title III for American textile manufacturing to strengthen the U.S. defense industrial base

Kraig Labs (OTCQB:KBLB) to create entirely new classes of industrial and defense materials with its "Project Atlas" bioengineering initiative

Kraig Biocraft Laboratories (OTCQB: KBLB) is the National Geographic March issue cover feature, which highlights major spider silk science breakthroughs